BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 17420670)

  • 1. Antihypertensive medications and risk of diabetes mellitus.
    Barzilay JI; Cutler JA; Davis BR
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):256-60. PubMed ID: 17420670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New onset diabetes during antihypertensive therapy.
    Alderman MH
    Am J Hypertens; 2008 May; 21(5):493-9. PubMed ID: 18437139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.
    Gress TW; Nieto FJ; Shahar E; Wofford MR; Brancati FL
    N Engl J Med; 2000 Mar; 342(13):905-12. PubMed ID: 10738048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-onset diabetes mellitus less deadly than elevated blood pressure? Following the evidence in the administration of thiazide diuretics.
    Phillips RA
    Arch Intern Med; 2006 Nov; 166(20):2174-6. PubMed ID: 17101933
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction.
    Mancia G
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S17-25. PubMed ID: 15868115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.
    Abuissa H; Jones PG; Marso SP; O'Keefe JH
    J Am Coll Cardiol; 2005 Sep; 46(5):821-6. PubMed ID: 16139131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-diabetic effect of blockade of the renin-angiotensin system.
    Ando K; Fujita T
    Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive agents and the risk of new onset diabetes mellitus].
    Kuzmanić D; Laganović M; Dika Z; Kos J; Pećin I
    Lijec Vjesn; 2006; 128(11-12):336-41. PubMed ID: 17212194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension therapy for type 2 diabetics].
    Bönner G
    MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC; Charlton J; Latinovic R
    J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Revival of antihypertensive therapy: use of thiazide diuretics].
    Nagy V
    Orv Hetil; 2004 Mar; 145(13):669-76. PubMed ID: 15125317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trandolapril / verapamil SR combination reverses drug-induced new-onset diabetes.
    Cardiovasc J Afr; 2008; 19(2):118. PubMed ID: 18516363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.